Could side effects of MDR-TB treatment change the outcome of the disease?

被引：0
|
作者：
Snene, Houda [1 ]
Daghfous, Hafaoua [1 ]
Ben Saad, Soumaya [1 ]
Ben Khelifa, Mouna [1 ]
Belhadj, Sameh [2 ]
Slim, Leila [3 ]
Tritar, Fatma [1 ]
机构：
[1] Hosp Abderrahmen Mami Ariana, Pulmonol Dept, Tunis, Tunisia
[2] Reg Hosp Menzel Bourguiba, Pulmonol Dept, Bizerte, Tunisia
[3] Hosp Abderrahmen Mami Ariana, Bacteriol, Tunis, Tunisia
来源：
EUROPEAN RESPIRATORY JOURNAL | 2015年 / 46卷
关键词：
MDR-TB; Tuberculosis; -; management; Treatments;
D O I：
10.1183/13993003.congress-2015.PA2707
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2707
引用
收藏
页数：3
相关论文
共 50 条
  • [21] MDR-TB and XDR-TB: drug resistance and treatment outcomes
    Khurana, A. K.
    Mohapatra, P. R.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (03) : 780 - 780
  • [22] Linezolid in the treatment of MDR-TB: a retrospective clinical study
    Xu, H-B.
    Jiang, R-H.
    Li, L.
    Xiao, H-P.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (03) : 358 - 363
  • [23] MDR-TB treatment outcomes in HIV positive patients
    Skrahina, Alena
    Khaliaukin, Andrei
    Hurevich, Henadz
    Zhylevich, Liudmila
    Rusovich, Valiantsin
    Belilovski, Evgeni
    Shyrayeu, Aliaksandr
    Dara, Masoud
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [24] STREAM: a pragmatic and explanatory trial for MDR-TB treatment
    Abubakar, Ibrahim
    Meredith, Sarah
    Nunn, Andrew J.
    Phillips, Patrick P. J.
    Rusen, I. D.
    [J]. LANCET INFECTIOUS DISEASES, 2019, 19 (06): : 575 - 576
  • [25] 'ZS-MDR-TB' versus 'ZR-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
    Zhang, Ying
    Chang, Kwok Chiu
    Leung, Chi-Chiu
    Yew, Wing Wai
    Gicquel, Brigitte
    Fallows, Dorothy
    Kaplan, Gilla
    Chaisson, Richard E.
    Zhang, Wenhong
    [J]. EMERGING MICROBES & INFECTIONS, 2012, 1
  • [26] Improved treatment outcome of MDR-TB in Eastern Taiwan: Reducing default rate by DOTS Plus
    Lin, Chih Bin
    Lee, Jen-Jyh
    Sun, Hung-Chieh
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [27] MDR-TB treatment needs in patients previously treated for TB in Cotonou, Benin
    Ade, S.
    Trebucq, A.
    Harries, A. D.
    Affolabi, D.
    Ade, G.
    Agodokpessi, G.
    Wachinou, P.
    Anagonou, S.
    Gninafon, M.
    [J]. PUBLIC HEALTH ACTION, 2013, 3 (02): : 160 - 165
  • [28] Outcome of hospitalized MDR-TB patients: Israel 2000-2005
    Bendayan, D.
    Hendler, A.
    Polansky, V.
    Weinberger, M.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (03) : 375 - 379
  • [29] Case Report: Kanamycin Ototoxicity and MDR-TB Treatment Regimen
    Mantefardo, Bahru
    Sisay, Gizaw
    [J]. INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2021, 14 : 815 - 817
  • [30] Screening with GenoTypeVR MTBDRplus shortens the time to MDR-TB treatment initiation but does not change outcomes
    Mendoza-Ticona, A.
    Mitnick, C. D.
    Obregon, G.
    Alarcon, V.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2023, 27 (12) : 949 - 951
12345